메뉴 건너뛰기




Volumn 46, Issue 1, 2014, Pages 29-34

Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: A double-blind randomized study

Author keywords

Cardiac index; CPB; Hemodynamic optimization; Inotropic agents; LCOS; Levosimendan; Off pump coronary artery bypass graft; OPCABG surgery; Pulmonary capillary wedge pressure

Indexed keywords

AMIODARONE; DOBUTAMINE; FUROSEMIDE; LEVOSIMENDAN; PLACEBO;

EID: 84893270046     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.125161     Document Type: Article
Times cited : (32)

References (20)
  • 1
    • 0141785597 scopus 로고    scopus 로고
    • The role of Ca++ -sensitizers for the treatment of heart failure
    • Lehmann A, Boldt J, Kirchner J. The role of Ca++ -sensitizers for the treatment of heart failure. Curr Opin Crit Care 2003;9: 337-44.
    • (2003) Curr Opin Crit Care , vol.9 , pp. 337-344
    • Lehmann, A.1    Boldt, J.2    Kirchner, J.3
  • 3
    • 33645498542 scopus 로고    scopus 로고
    • Levosimendan, a new inotropic and vasodilator agent
    • Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006;104: 556-69.
    • (2006) Anesthesiology , vol.104 , pp. 556-569
    • Toller, W.G.1    Stranz, C.2
  • 5
    • 70349330345 scopus 로고    scopus 로고
    • Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation
    • Liu T, Li G, Xu G. Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation. J Cardiothorac Vasc Anesth 2009;23: 757-8.
    • (2009) J Cardiothorac Vasc Anesth , vol.23 , pp. 757-758
    • Liu, T.1    Li, G.2    Xu, G.3
  • 7
    • 5644302941 scopus 로고    scopus 로고
    • Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators
    • Antila S, Pesonen U, Lehtonen L, Tapanainen P, Nikkanen H, Vaahtera K, et al. Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators. Eur J Pharm Sci 2004;23: 213-22.
    • (2004) Eur J Pharm Sci , vol.23 , pp. 213-222
    • Antila, S.1    Pesonen, U.2    Lehtonen, L.3    Tapanainen, P.4    Nikkanen, H.5    Vaahtera, K.6
  • 8
    • 0041414825 scopus 로고    scopus 로고
    • United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Off-Pump Coronary Artery Bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: A United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome
    • Al-Ruzzeh S, Ambler G, Asimakopoulos G, Omar RZ, Hasan R, Fabri B, et al. United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Off-Pump Coronary Artery Bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: A United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Circulation 2003;108 Suppl 1: 1-8.
    • (2003) Circulation , vol.108 , Issue.SUPPL. 1 , pp. 1-8
    • Al-Ruzzeh, S.1    Ambler, G.2    Asimakopoulos, G.3    Omar, R.Z.4    Hasan, R.5    Fabri, B.6
  • 10
    • 0031976338 scopus 로고    scopus 로고
    • Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
    • Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19: 660-8.
    • (1998) Eur Heart J , vol.19 , pp. 660-668
    • Lilleberg, J.1    Nieminen, M.S.2    Akkila, J.3    Heikkilä, L.4    Kuitunen, A.5    Lehtonen, L.6
  • 11
    • 0034739460 scopus 로고    scopus 로고
    • Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators
    • Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000;102: 2222-7.
    • (2000) Circulation , vol.102 , pp. 2222-2227
    • Slawsky, M.T.1    Colucci, W.S.2    Gottlieb, S.S.3    Greenberg, B.H.4    Haeusslein, E.5    Hare, J.6
  • 14
    • 27144485340 scopus 로고    scopus 로고
    • Effects of levosimendan on restrictive left ventricular filling in sever heart failure: A combined hemodynamic and Doppler echocardiographic study
    • Dernellis J, Panaretou M. Effects of levosimendan on restrictive left ventricular filling in sever heart failure: A combined hemodynamic and Doppler echocardiographic study. Chest 2005;128: 2633-9.
    • (2005) Chest , vol.128 , pp. 2633-2639
    • Dernellis, J.1    Panaretou, M.2
  • 15
    • 2142775424 scopus 로고    scopus 로고
    • Levosimendan in patients with low-output heart failure: Lessons from the LIDO trial
    • Follath F. Levosimendan in patients with low-output heart failure: Lessons from the LIDO trial. Ital Heart J 2003;42:34-8S.
    • (2003) Ital Heart J , vol.42
    • Follath, F.1
  • 16
    • 34548428716 scopus 로고    scopus 로고
    • Efficacy and safety of perioperative infusion of levosimendan in patient with compromised cardiac function undergoing open-heart surgery: Importance of early use
    • Tasouli A, Papadoupolos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, et al. Efficacy and safety of perioperative infusion of levosimendan in patient with compromised cardiac function undergoing open-heart surgery: Importance of early use. Eur J Cardiothoracic Surg 2007;32: 629-33.
    • (2007) Eur J Cardiothoracic Surg , vol.32 , pp. 629-633
    • Tasouli, A.1    Papadoupolos, K.2    Antoniou, T.3    Kriaras, I.4    Stavridis, G.5    Degiannis, D.6
  • 17
    • 31744440374 scopus 로고    scopus 로고
    • Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial
    • Husedzinović I, Barisin S, Bradić N, Barisin A, Sonicki Z, Milanović R. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial. Croat Med J 2005;46: 950-6.
    • (2005) Croat Med J , vol.46 , pp. 950-956
    • Husedzinović, I.1    Barisin, S.2    Bradić, N.3    Barisin, A.4    Sonicki, Z.5    Milanović, R.6
  • 18
    • 58449130982 scopus 로고    scopus 로고
    • Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery
    • Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009;102: 198-204.
    • (2009) Br J Anaesth , vol.102 , pp. 198-204
    • Tritapepe, L.1    De Santis, V.2    Vitale, D.3    Guarracino, F.4    Pellegrini, F.5    Pietropaoli, P.6
  • 19
    • 84867485658 scopus 로고    scopus 로고
    • Preoperative levosimendan decreases mortality and the development of low cardiac output in high risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass
    • Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Cli Cardiol 2012;17: 1-6.
    • (2012) Exp Cli Cardiol , vol.17 , pp. 1-6
    • Levin, R.1    Degrange, M.2    Del Mazo, C.3    Tanus, E.4    Porcile, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.